← FDA Drug Approvals (Drugs@FDA)

PREDNISONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: POINTVIEW HLDINGS · Approved 2023-12-05

Drug application

FDA Application #

ANDA212629

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREDNISONE

Generic name

PREDNISONE

Active ingredients

PREDNISONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

POINTVIEW HLDINGS

Manufacturer

Granulation Technology, Inc.

First approval

2023-12-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown